Renova Therapeutics is working to create transformational gene therapies and peptide infusions that treat the most prevalent chronic diseases.
Total raised: $7.52M
Investors 1
| Date | Name | Website |
| - | Biobrit | biobrit.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.11.2014 | - | $7.52M | - |
Mentions in press and media 2
| Date | Title | Description |
| 07.02.2017 | GW touts positive survival benefit in small brain cancer study; Ablynx files for ultra-rare disease drug OK | • GW Pharma is touting claims that a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) produced positive survival benefits in a small study of 21 patients with recurrent glioblastoma multiforme, a common... |
| 18.11.2014 | Renova Therapeutics Raises $7.52M | San Diego-based Renova Therapeutics, a biopharmaceuticals company developing treatments for congestive heart failure and other diseases, has raised $7.52M in a Series C funding round. The company said the funding primarily came from high ne... |